Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study

Biotherapy. 1996;9(1-3):143-7. doi: 10.1007/BF02628672.

Abstract

40 infantile autistic patients were studied. They ranged from 6 years to 15 years of age at entry. 22 were cases of classical infantile autism; whereas 18 lacked one or more clinical defects associated with infantile autism ("pseudo-autism"). Of the 22 with classic autism, 21 responded to transfer factor (TF) treatment by gaining at least 2 points in symptoms severity score average (SSSA); and 10 became normal in that they were main-streamed in school and clinical characteristics were fully normalized. Of the 18 remaining, 4 responded to TF, some to other therapies. After cessation of TF therapy, 5 in the autistic group and 3 of the pseudo-autistic group regressed, but they did not drop as low as baseline levels.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Antibodies / analysis
  • Autistic Disorder / immunology
  • Autistic Disorder / therapy*
  • Cell Extracts / therapeutic use*
  • Child
  • Dialysis
  • Follow-Up Studies
  • Humans
  • Lymphocytes / chemistry
  • Lymphocytes / immunology*
  • Myelin Basic Protein / immunology
  • Pilot Projects
  • Transfer Factor / therapeutic use*

Substances

  • Antibodies
  • Cell Extracts
  • Myelin Basic Protein
  • Transfer Factor